Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
A Survey of Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
1 other identifier
observational
200
1 country
1
Brief Summary
The main objectives of this study were :(1) to comprehensively and systematically evaluate the nutritional status of patients after hematopoietic stem cell transplantation. (2) to explore the effect of nutritional factors on the prognosis of patients treated by hematopoietic stem cell transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
March 19, 2026
March 1, 2026
8.3 years
October 14, 2019
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Change from Baseline fat free mass at 6 months
Body composition analyzer INBO DY S10 (bioelectrical impedance method) is used to analyze the content of fat free mass( kilograms)
6 months
Change from Baseline fat mass at 6 months
Body composition analyzer INBODY S10 (bioelectrical impedance method) is used to analyze the content of fat mass( kilograms)
6 months
Change from Baseline food intake at 6 months
24-hour dietary record and semi-quantitative food frequency questionnaire are used to evaluate the eating condition of patients
6 months
Change from Baseline albumin level in blood at 6 months
The content of albumin in blood is determined.
6 months
Secondary Outcomes (2)
Overall survial
3 years
Event free survival
3 years
Interventions
not have
Eligibility Criteria
Patients who have received hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University
You may qualify if:
- Patients who undergo hematopoietic stem cell transplantation in the First Affiliated Hospital of Soochow University.
- Having a life expectancy of more than 3 months
You may not qualify if:
- Not willing to participate in the investigation
- Age less than 15 years old or more than 80 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The first affiliated hospital of suzhou university
Suzhou, Jiangsu, 215000, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 31, 2019
Study Start
October 1, 2018
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03